Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 CAD | -7.14% | -9.72% | -32.99% |
Apr. 26 | BioNxt Solutions Inc. Announces ODF Cladribine Update | CI |
Apr. 26 | BioNxt Solutions Inc. announced that it expects to receive CAD 1.62 million in funding | CI |
Sales 2022 | 0.3 0.41 | Sales 2023 | 0.37 0.51 | Capitalization | 52.06M 71.46M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.47M | Net income 2023 | -7M -9.61M | EV / Sales 2022 | 195,159,524 x |
Net Debt 2022 | 4.23M 5.81M | Net Debt 2023 | 4.53M 6.22M | EV / Sales 2023 | 152,035,600 x |
P/E ratio 2022 |
-3.99
x | P/E ratio 2023 |
-6.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.75% |
1 day | -7.14% | ||
1 week | -9.72% | ||
Current month | -30.85% | ||
1 month | -35.00% | ||
3 months | -50.00% | ||
6 months | +20.37% | ||
Current year | -32.99% |
Managers | Title | Age | Since |
---|---|---|---|
Hugh Rogers
CEO | Chief Executive Officer | 44 | 17-12-11 |
P. Meagher
DFI | Director of Finance/CFO | 39 | 21-11-18 |
Wolfgang Probst
BRD | Director/Board Member | 43 | 18-12-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
P. Meagher
DFI | Director of Finance/CFO | 39 | 21-11-18 |
Hugh Rogers
CEO | Chief Executive Officer | 44 | 17-12-11 |
Raimar Löbenberg
BRD | Director/Board Member | 58 | 18-12-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.325 | -7.14% | 500 |
24-05-01 | 0.33 | -17.50% | 2,500 |
24-04-26 | 0.4 | +11.11% | 12,500 |
24-04-23 | 0.36 | 0.00% | 10,500 |
Delayed Quote Canadian Securities Exchange, May 02, 2024 at 09:39 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.99% | 26.27M | |
+31.49% | 699B | |
+26.24% | 571B | |
-4.19% | 364B | |
+18.13% | 326B | |
+2.51% | 286B | |
+14.62% | 236B | |
+4.56% | 198B | |
-11.86% | 194B | |
-4.36% | 154B |
- Stock Market
- Equities
- BNXT Stock